Hsing-Ying Ho
About
In The Last Decade
Hsing-Ying Ho
30 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 718
- Infectious Diseases 351
- Molecular Biology 233
- Epidemiology 225
- Pathology and Forensic Medicine 188
Countries citing papers authored by Hsing-Ying Ho
This map shows the geographic impact of Hsing-Ying Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsing-Ying Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsing-Ying Ho more than expected).
Fields of papers citing papers by Hsing-Ying Ho
This network shows the impact of papers produced by Hsing-Ying Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsing-Ying Ho. The network helps show where Hsing-Ying Ho may publish in the future.
Co-authorship network of co-authors of Hsing-Ying Ho
This figure shows the co-authorship network connecting the top 25 collaborators of Hsing-Ying Ho. A scholar is included among the top collaborators of Hsing-Ying Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsing-Ying Ho. Hsing-Ying Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 13 | |
| 6 | 15 | |
| 7 | 55 | |
| 8 | 11 | |
| 9 | 13 | |
| 10 | 14 | |
| 11 | 0 | |
| 12 | 15 | |
| 13 | 19 | |
| 14 | 10 | |
| 15 | 2 | |
| 16 | 3 | |
| 17 | Nasopharyngeal carcinoma V: immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor. | 21 |
| 18 | Antibodies to Epstein-Barr Virus in Nasopharyngeal Carcinoma, Other Head and Neck Neoplasms, and Control Groups<xref ref-type="fn" rid="FN2">2</xref> breakdown → | 341 |
| 19 | Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. | 113 |
| 20 | 41 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.